Clinical Trial Update: The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing the HIV functional cure potential of UB-421 in ART-stabilized HIV-1 patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• UB-421 (anti-CD4 antibody)

Snippet

Sponsor: United BioPharma | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED